Replication-Competent Infectious Hepatitis B Virus Vectors Carrying Substantially Sized Transgenes by Redesigned Viral Polymerase Translation

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Wang, Zihua ^a,b   Wu, Li ^a,d   Cheng, Xin ^a   Liu, Shizhu ^a   Li, Baosheng ^a   Li, Haijun ^a   Kang, Fubiao ^a   Wang, Junping ^a   Xia, Huan ^a   Ping, Caiyan ^a   Nassal, Michael ^c   Sun, Dianxing ^a  

^a BETHUNE INTERNATIONAL PEACE HOSPITAL   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF FREIBURG   (Germany)

^d Baoding Hospital for Infectious Diseases   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC RNA; PLASMID VECTOR; REPLICATION COMPETENT VIRUS VECTOR; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS VECTOR;

ARTICLE; BLASTICIDIN RESISTANCE GENE; CELL STRAIN HEPG2; CONTROLLED STUDY; GENOME ANALYSIS; GENOME SIZE; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; INTERNAL RIBOSOME ENTRY SITE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; TRANSGENE; TRANSLATION REGULATION; VIRION; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS TRANSCRIPTION; WILD TYPE;

CELL LINE; GENE EXPRESSION REGULATION, VIRAL; GENE ORDER; GENE PRODUCTS, POL; GENES, REPORTER; GENETIC VECTORS; GENOME, VIRAL; HEPATITIS B VIRUS; HUMANS; PROTEIN TRANSPORT; RNA, VIRAL; RNA-BINDING PROTEINS; TRANSGENES; VIRION; VIRUS REPLICATION;

DNA VIRUSES; HEPATITIS B VIRUS; MIRIDAE; RENILLA;

EID: 84875658082     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060306     Document Type: Article

References (76)

1. WHO (2008) Hepatitis B. Fact sheet no 204.
2. Ganem D, Prince AM, (2004) Hepatitis B virus infection--natural history and clinical consequences. N Engl J Med 350: 1118-1129.
3. Nassal M, (2009) New insights into HBV replication: new opportunities for improved therapies. Future Virol 4: 55-70.
4. von Weizsäcker F, Köck J, MacNelly S, Ren S, Blum HE, et al. (2004) The tupaia model for the study of hepatitis B virus: direct infection and HBV genome transduction of primary tupaia hepatocytes. Methods Mol Med 96: 153-161.
5. Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, et al. (2002) Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A 99: 15655-15660.
6. Beck J, Nassal M, (2007) Hepatitis B virus replication. World J Gastroenterol 13: 48-64.
7. Nassal M, (2008) Hepatitis B viruses: reverse transcription a different way. Virus Res 134: 235-249.
8. Müller B, Daecke J, Fackler OT, Dittmar MT, Zentgraf H, et al. (2004) Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative. J Virol 78: 10803-10813.
9. Terahara K, Yamamoto T, Mitsuki YY, Shibusawa K, Ishige M, et al. (2011) Fluorescent Reporter Signals, EGFP, and DsRed, Encoded in HIV-1 Facilitate the Detection of Productively Infected Cells and Cell-Associated Viral Replication Levels. Front Microbiol 2: 280.
10. Bühler S, Bartenschlager R, (2012) New targets for antiviral therapy of chronic hepatitis C. Liver Int 32Suppl 1: 9-16.
11. Tai AW, Benita Y, Peng LF, Kim SS, Sakamoto N, et al. (2009) A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host Microbe 5: 298-307.
12. Reiss S, Rebhan I, Backes P, Romero-Brey I, Erfle H, et al. (2011) Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. Cell Host Microbe 9: 32-45.
13. Berke JM, Fenistein D, Pauwels F, Bobbaers R, Lenz O, et al. (2010) Development of a high-content screening assay to identify compounds interfering with the formation of the hepatitis C virus replication complex. J Virol Methods 165: 268-276.
14. Zoulim F, Saputelli J, Seeger C, (1994) Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol 68: 2026-2030.
15. Hantz O, Parent R, Durantel D, Gripon P, Guguen-Guillouzo C, et al. (2009) Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells. J Gen Virol 90: 127-135.
16. Lucifora J, Arzberger S, Durantel D, Belloni L, Strubin M, et al. (2011) Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. Journal of hepatology 55: 996-1003.
17. Ou JH, Bao H, Shih C, Tahara SM, (1990) Preferred translation of human hepatitis B virus polymerase from core protein- but not from precore protein-specific transcript. J Virol 64: 4578-4581.
18. Protzer U, Nassal M, Chiang PW, Kirschfink M, Schaller H, (1999) Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection. Proc Natl Acad Sci U S A 96: 10818-10823.
19. Untergasser A, Protzer U, (2004) Hepatitis B virus-based vectors allow the elimination of viral gene expression and the insertion of foreign promoters. Hum Gene Ther 15: 203-210.
20. Li SH, Huang WG, Huang B, Chen XG, (2007) High expression of hepatitis B virus based vector with reporter gene in hepatitis B virus infection system. World J Gastroenterol 13: 2490-2495.
21. Liu JX, Sun DX, Cao ZC, (2009) [Stable cell line for secretion of replication-defective hepatitis B virus vector expressing blasticidin resistant gene]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 23: 316-318.
22. Yoo J, Rho J, Lee D, Shin S, Jung G, (2002) Hepatitis B virus vector carries a foreign gene into liver cells in vitro. Virus Genes 24: 215-224.
23. Liu J, Xin C, Guo Z, Wang Z, Li D, et al. (2013) Truncated Active Human Matrix Metalloproteinase-8 Delivered by a Chimeric Adenovirus-Hepatitis B Virus Vector Ameliorates Rat Liver Cirrhosis. PLoS ONE 8(1): e53392 doi:10.1371/journal.pone.0053392.
24. Chaisomchit S, Tyrrell DL, Chang LJ, (1997) Development of replicative and nonreplicative hepatitis B virus vectors. Gene Ther 4: 1330-1340.
25. Chen A, Kao YF, Brown CM, (2005) Translation of the first upstream ORF in the hepatitis B virus pregenomic RNA modulates translation at the core and polymerase initiation codons. Nucleic Acids Res 33: 1169-1181.
26. Walsh D, Mohr I, (2011) Viral subversion of the host protein synthesis machinery. Nat Rev Microbiol 9: 860-875.
27. Bartenschlager R, Schaller H, (1992) Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome. EMBO J 11: 3413-3420.
28. Porterfield JZ, Dhason MS, Loeb DD, Nassal M, Stray SJ, et al. (2010) Full-length hepatitis B virus core protein packages viral and heterologous RNA with similarly high levels of cooperativity. J Virol 84: 7174-7184.
29. Wang JC, Dhason MS, Zlotnick A, (2012) Structural organization of pregenomic RNA and the carboxy-terminal domain of the capsid protein of hepatitis B virus. PLoS Pathog 8: e1002919.
30. Nassal M, (1992) The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J Virol 66: 4107-4116.
31. Dhason MS, Wang JC, Hagan MF, Zlotnick A, (2012) Differential assembly of Hepatitis B Virus core protein on single- and double-stranded nucleic acid suggest the dsDNA-filled core is spring-loaded. Virology 430: 20-29.
32. Sharma P, Yan F, Doronina VA, Escuin-Ordinas H, Ryan MD, et al. (2012) 2A peptides provide distinct solutions to driving stop-carry on translational recoding. Nucleic Acids Res 40: 3143-3151.
33. Jang SK, Wimmer E, (1990) Cap-independent translation of encephalomyocarditis virus RNA: structural elements of the internal ribosomal entry site and involvement of a cellular 57-kD RNA-binding protein. Genes Dev 4: 1560-1572.
34. Ngoi SM, Chien AC, Lee CG, (2004) Exploiting internal ribosome entry sites in gene therapy vector design. Curr Gene Ther 4: 15-31.
35. Baird SD, Turcotte M, Korneluk RG, Holcik M, (2006) Searching for IRES. RNA 12: 1755-1785.
36. Chappell SA, Mauro VP, (2003) The internal ribosome entry site (IRES) contained within the RNA-binding motif protein 3 (Rbm3) mRNA is composed of functionally distinct elements. J Biol Chem 278: 33793-33800.
37. Baranick BT, Lemp NA, Nagashima J, Hiraoka K, Kasahara N, et al. (2008) Splicing mediates the activity of four putative cellular internal ribosome entry sites. Proc Natl Acad Sci U S A 105: 4733-4738.
38. Haase R, Argyros O, Wong SP, Harbottle RP, Lipps HJ, et al. (2010) pEPito: a significantly improved non-viral episomal expression vector for mammalian cells. BMC Biotechnol 10: 20.
39. Licursi M, Christian SL, Pongnopparat T, Hirasawa K, (2011) In vitro and in vivo comparison of viral and cellular internal ribosome entry sites for bicistronic vector expression. Gene Ther 18: 631-636.
40. Sun D, Nassal M, (2006) Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus. J Hepatol 45: 636-645.
41. Li D, Liu J, Kang F, Guan W, Gao X, et al. (2011) Core-APOBEC3C chimerical protein inhibits hepatitis B virus replication. J Biochem 150: 371-374.
42. Ohori H, Yamaki M, Onodera S, Yamada E, Ishida N, (1980) Antigenic conversion from HBcAg to HBeAg by degradation of hepatitis B core particles. Intervirology 13: 74-82.
43. Köck J, Rösler C, Zhang J, Blum HE, Nassal M, et al. (2012) Human hepatitis B virus production in avian cells is characterized by enhanced RNA splicing and the presence of capsids containing shortened genomes. PLoS One 7: e37248.
44. Kozak M, (1987) An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 15: 8125-8148.
45. Raney AK, Easton AJ, McLachlan A, (1994) Characterization of the minimal elements of the hepatitis B virus large surface antigen promoter. J Gen Virol 75 (Pt 10): 2671-2679.
46. Ren S, Nassal M, (2001) Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors. J Virol 75: 1104-1116.
47. Bardens A, Doring T, Stieler J, Prange R, (2011) Alix regulates egress of hepatitis B virus naked capsid particles in an ESCRT-independent manner. Cell Microbiol 13: 602-619.
48. Schulze A, Mills K, Weiss TS, Urban S, (2012) Hepatocyte polarization is essential for the productive entry of the hepatitis B virus. Hepatology 55: 373-383.
49. Lohmann V, Korner F, Koch J, Herian U, Theilmann L, et al. (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285: 110-113.
50. Koutsoudakis G, Kaul A, Steinmann E, Kallis S, Lohmann V, et al. (2006) Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J Virol 80: 5308-5320.
51. Pietschmann T, Kaul A, Koutsoudakis G, Shavinskaya A, Kallis S, et al. (2006) Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci U S A 103: 7408-7413.
52. Lentz TB, Gray SJ, Samulski RJ, (2012) Viral vectors for gene delivery to the central nervous system. Neurobiol Dis 48: 179-188.
53. Li F, Feng L, Pan W, Dong Z, Li C, et al. (2010) Generation of replication-competent recombinant influenza A viruses carrying a reporter gene harbored in the neuraminidase segment. J Virol 84: 12075-12081.
54. Manicassamy B, Manicassamy S, Belicha-Villanueva A, Pisanelli G, Pulendran B, et al. (2010) Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proceedings of the National Academy of Sciences of the United States of America 107: 11531-11536.
55. Edmonds TG, Ding H, Yuan X, Wei Q, Smith KS, et al. (2010) Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC. Virology 408: 1-13.
56. Hernandez-Alcoceba R, (2011) Recent advances in oncolytic virus design. Clin Transl Oncol 13: 229-239.
57. Bartenschlager R, Junker-Niepmann M, Schaller H, (1990) The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation. J Virol 64: 5324-5332.
58. van Breugel PC, Robert EI, Mueller H, Decorsiere A, Zoulim F, et al. (2012) Hepatitis B virus x protein stimulates gene expression selectively from extrachromosomal DNA templates. Hepatology.
59. Bett AJ, Prevec L, Graham FL, (1993) Packaging capacity and stability of human adenovirus type 5 vectors. J Virol 67: 5911-5921.
60. Chua PK, Tang FM, Huang JY, Suen CS, Shih C, (2010) Testing the balanced electrostatic interaction hypothesis of hepatitis B virus DNA synthesis by using an in vivo charge rebalance approach. J Virol 84: 2340-2351.
61. Lewellyn EB, Loeb DD, (2007) Base pairing between cis-acting sequences contributes to template switching during plus-strand DNA synthesis in human hepatitis B virus. J Virol 81: 6207-6215.
62. Maguire ML, Loeb DD, (2010) cis-Acting sequences that contribute to synthesis of minus-strand DNA are not conserved between hepadnaviruses. J Virol 84: 12824-12831.
63. Chappell SA, Edelman GM, Mauro VP, (2000) A 9-nt segment of a cellular mRNA can function as an internal ribosome entry site (IRES) and when present in linked multiple copies greatly enhances IRES activity. Proc Natl Acad Sci U S A 97: 1536-1541.
64. Tannous BA, Kim DE, Fernandez JL, Weissleder R, Breakefield XO, (2005) Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther 11: 435-443.
65. Drocourt D, Calmels T, Reynes JP, Baron M, Tiraby G, (1990) Cassettes of the Streptoalloteichus hindustanus ble gene for transformation of lower and higher eukaryotes to phleomycin resistance. Nucleic Acids Res 18: 4009.
66. Shu X, Lev-Ram V, Deerinck TJ, Qi Y, Ramko EB, et al. (2011) A genetically encoded tag for correlated light and electron microscopy of intact cells, tissues, and organisms. PLoS Biol 9: e1001041.
67. Qi YB, Garren EJ, Shu X, Tsien RY, Jin Y, (2012) Photo-inducible cell ablation in Caenorhabditis elegans using the genetically encoded singlet oxygen generating protein miniSOG. Proc Natl Acad Sci U S A 109: 7499-7504.
68. Freed WJ, Zhang P, Sanchez JF, Dillon-Carter O, Coggiano M, et al. (2005) Truncated N-terminal mutants of SV40 large T antigen as minimal immortalizing agents for CNS cells. Exp Neurol 191Suppl 1: S45-59.
69. Galibert F, Mandart E, Fitoussi F, Tiollais P, Charnay P, (1979) Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 281: 646-650.
70. Sun D, Rösler C, Kidd-Ljunggren K, Nassal M, (2010) Quantitative assessment of the antiviral potencies of 21 shRNA vectors targeting conserved, including structured, hepatitis B virus sites. J Hepatol 52: 817-826.
71. Heijtink RA, Kruining J, Weber YA, de Man RA, Schalm SW, (1995) Anti-hepatitis B virus activity of a mixture of two monoclonal antibodies in an "inhibition in solution" assay. Hepatology 22: 1078-1083.
72. Sällberg M, Ruden U, Magnius LO, Harthus HP, Noah M, et al. (1991) Characterisation of a linear binding site for a monoclonal antibody to hepatitis B core antigen. J Med Virol 33: 248-252.
73. King RW, Ladner SK, Miller TJ, Zaifert K, Perni RB, et al. (1998) Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L-2′,3′-dideoxy-3′-thiacytidine. Antimicrob Agents Chemother 42: 3179-3186.
74. Tajiri K, Ozawa T, Jin A, Tokimitsu Y, Minemura M, et al. (2010) Analysis of the epitope and neutralizing capacity of human monoclonal antibodies induced by hepatitis B vaccine. Antiviral Res 87: 40-49.
75. Pasek M, Goto T, Gilbert W, Zink B, Schaller H, et al. (1979) Hepatitis B virus genes and their expression in E. coli. Nature 282: 575-579.
76. Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, et al. (1988) Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 69: 2575-2583.